GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Equity-to-Asset

Hyphens Pharma International (SGX:1J5) Equity-to-Asset : 0.52 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hyphens Pharma International's Total Stockholders Equity for the quarter that ended in Dec. 2024 was S$70.9 Mil. Hyphens Pharma International's Total Assets for the quarter that ended in Dec. 2024 was S$135.8 Mil. Therefore, Hyphens Pharma International's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.52.

The historical rank and industry rank for Hyphens Pharma International's Equity-to-Asset or its related term are showing as below:

SGX:1J5' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32   Med: 0.52   Max: 0.6
Current: 0.52

During the past 10 years, the highest Equity to Asset Ratio of Hyphens Pharma International was 0.60. The lowest was 0.32. And the median was 0.52.

SGX:1J5's Equity-to-Asset is ranked better than
55.25% of 686 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs SGX:1J5: 0.52

Hyphens Pharma International Equity-to-Asset Historical Data

The historical data trend for Hyphens Pharma International's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Equity-to-Asset Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.55 0.60 0.52 0.52

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.60 0.52 0.50 0.52

Competitive Comparison of Hyphens Pharma International's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyphens Pharma International's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's Equity-to-Asset falls into.


;
;

Hyphens Pharma International Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hyphens Pharma International's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=70.898/135.75
=0.52

Hyphens Pharma International's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=70.898/135.75
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International  (SGX:1J5) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Hyphens Pharma International Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment; and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International Headlines

No Headlines